title: The hemorrhage of information to reduce bleeding complications after percutaneous coronary intervention.
authors.affiliation: Detroit Medical Center Cardiovascular Institute, Detroit, Michigan; and Wayne State University, Detroit, Michigan.
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
authors.forename: Theodore
authors.initials: T
authors.lastname: Schreiber
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006328:Cardiac Catheterization / Q000009:adverse effects*; D003094:Collagen / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000008:administration & dosage*; D006629:Hirudins / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D008297:Male; D009203:Myocardial Infarction / Q000601:surgery*; D010446:Peptide Fragments / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects* / Q000379:methods*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D065506:Vascular Closure Devices / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D000991:Antithrombins; D006629:Hirudins; D007140:Immunoglobulin Fab Fragments; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; D003094:Collagen; C074619:bivalirudin; D000077284:Abciximab